CLEVELAND, Ohio — Cleveland Clinic’s top fund-raising administrator is leaving the system for a similar position at the University of California San Francisco.
As the Clinic’s chairwoman of institutional relations and development, Carol Moss oversees the organization’s five-year, $1.25 billion Campaign for Cleveland Clinic (the drive reached $1 billion last year). Private support nearly doubled the year after she took over in 2007, and Moss is also credited for initiatives that added more physicians into fund-raising efforts.
She will become vice chancellor of University Development and Alumni Relations at UCSF starting Oct. 1. She will also serve as vice president of the UCSF Foundation. Salary for the position is $376,600, according to the university.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Fund-raising was sure to become more challenging at the Clinic. Its portfolio (like many charitable organizations) took a crushing blow in the past year. But Moss will have an equal challenge — at the least — in California. The state-supported university needs to strengthen its development office to counter a state in financial crisis, and it is in the midst of a $600 million campaign to build build a new children’s and women’s specialty and cancer hospital, and will launch a $150 million effort to support its neurosciences research.
“As we cope with multi-million dollar budget reductions caused by the state’s budget crisis, it is imperative that we strengthen our development program so UCSF continues to excel at the leading edge of scientific discovery, patient care and graduate-level education in the life sciences and health professions,” university Chancellor Susan Desmond-Hellmann stated in a press release.
No word yet on Moss’ replacement.
